TABLE 4.
ER+ (n = 1293) | ER− (n = 205) | |||||
---|---|---|---|---|---|---|
Servings/mo | Controls (n = 1202), n | n | OR (95% CI) | n | OR (95% CI) | P-heterogeneity |
Total dairy | 0.24 | |||||
0–14 | 245 | 301 | 1.00 | 72 | 1.00 | |
>14 to 28 | 250 | 326 | 1.11 (0.87, 1.42) | 70 | 0.97 (0.66, 1.43) | |
>28 to 42 | 241 | 249 | 0.91 (0.70, 1.18) | 64 | 0.99 (0.66, 1.46) | |
>42 | 466 | 417 | 0.82 (0.64, 1.04) | 119 | 1.00 (0.68, 1.46) | |
Milk | 0.04 | |||||
0 | 322 | 355 | 1.00 | 76 | 1.00 | |
>0 to 14 | 535 | 586 | 0.90 (0.74, 1.11) | 142 | 1.03 (0.74, 1.42) | |
>14 to 28 | 172 | 178 | 0.87 (0.66, 1.14) | 46 | 1.12 (0.74, 1.71) | |
>28 | 173 | 174 | 0.88 (0.67, 1.16) | 61 | 1.58 (1.05, 2.37) | |
Yogurt | 0.73 | |||||
0 | 196 | 290 | 1.00 | 74 | 1.00 | |
≤14 | 843 | 883 | 0.81 (0.66, 1.00) | 218 | 0.72 (0.52, 0.98) | |
>14 | 163 | 120 | 0.65 (0.48, 0.89) | 33 | 0.61 (0.38, 0.99) | |
Low-fat cheese | 0.23 | |||||
0 | 115 | 125 | 1.00 | 40 | 1.00 | |
≤14 | 958 | 1062 | 1.06 (0.80, 1.40) | 264 | 0.82 (0.55, 1.23) | |
>14 | 129 | 106 | 0.92 (0.63, 1.35) | 21 | 0.54 (0.29, 0.99) | |
Other cheese | 0.92 | |||||
0 | 63 | 58 | 1.00 | 13 | 1.00 | |
≤14 | 1034 | 1125 | 1.32 (0.90, 1.93) | 283 | 1.31 (0.70, 2.42) | |
>14 | 105 | 110 | 1.56 (0.97, 2.50) | 29 | 1.44 (0.68, 3.03) | |
Sweet dairy | ||||||
0 | 41 | 56 | 1.00 | 0.01 | ||
>0 to 14 | 974 | 1074 | 0.82 (0.54, 1.26) | 276 | 1.002 | |
>14 to 28 | 136 | 124 | 0.68 (0.42, 1.11) | 29 | 0.82 (0.53, 1.26) | |
>28 | 51 | 39 | 0.52 (0.29, 0.95) | 20 | 1.55 (0.89, 2.70) |
ORs and 95% CIs estimated with unconditional logistic regression while adjusting for age, race, BMI, menopausal status, energy intake, type of milk usually consumed (nonfat, low-fat, whole, or nondairy milk), cigarette smoking status, and family history of breast cancer. ER, estrogen receptor.
Categories collapsed to 0–14, >14 to 28, and >28 for ER negative cancer.